First, tirzepatide is a dual agonist (targeting both GLP-1 and GIP receptors) and has proven results for weight loss and glycemic control
Book an appointment today for a personalized consultwell test your levels, talk through your story, and design a plan that fits you
Third, lifestyle modifications including nutrition counseling and physical activity should be implemented concurrently
We anticipate a significant difference in peri- and postoperative complications in patients with severe diabetes and disease sequelae, before and following the implementation of the ASA GLP-1 guidelines to hold GLP-1RA therapy prior to procedures requiring general anesthesia
Insulin helps move sugar from the bloodstream into cells for energy
Semaglutide has been approved for reducing the risk of major adverse cardiovascular events in patients with obesity and heart disease, as well as for preventing the progression of kidney disease in individuals with type 2 diabetes and chronic kidney disease